California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

Press releases published on April 27, 2026

Apr. 27, 2026

Cardiff Oncology to Host Key Opinion Leader Discussion on Onvansertib’s Promising Single-Agent Activity

Indeterminate GlobeNewswire

Apr. 27, 2026

Sagimet Biosciences Provides Strategic and Corporate Updates

Indeterminate GlobeNewswire

Apr. 27, 2026

Ocular Therapeutix™ to Participate in May Scientific and Investor Conferences

Indeterminate GlobeNewswire

Apr. 27, 2026

Seer Board of Directors Unanimously Rejects Revised Unsolicited Proposal from Radoff-JEC Group

Indeterminate GlobeNewswire

Apr. 27, 2026

Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator

Indeterminate GlobeNewswire

Apr. 27, 2026

Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator 

Indeterminate GlobeNewswire

Apr. 27, 2026

Fulcrum Therapeutics Appoints Josh Lehrer to its Board of Directors

Indeterminate GlobeNewswire

Apr. 27, 2026

Eton Pharmaceuticals Announces Initiation of Clinical Study for Product Candidate ET-700

Indeterminate GlobeNewswire

Apr. 27, 2026

Conference to focus on how artificial intelligence can dramatically reduce workplace injuries

Indeterminate GlobeNewswire

Apr. 27, 2026

Relay Therapeutics Announces Clinical Data for Zovegalisib plus Atirmociclib Triplet Combination Supportive of Further Development in Frontline Metastatic Breast Cancer

Indeterminate GlobeNewswire

Apr. 27, 2026

KFSH Highlights Scalable AI Integration Model at C3 Davos of Healthcare™ Silicon Valley Summit

Indeterminate GlobeNewswire

Apr. 27, 2026

AtaiBeckley and PsyPAN Receive a Silver Award in 2026 Patient Participant Index, Reflecting Ongoing Commitment to Participant-Informed Research

Indeterminate GlobeNewswire

Apr. 27, 2026

Fangzhou Publishes 2025 Annual Report, Advancing AI-Powered Chronic Care Strategy for 2026

Indeterminate GlobeNewswire

Apr. 27, 2026

OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation Granted to Pegrizeprument (VEL-101) for Prevention of Organ Rejection in Heart Transplant Patients

Indeterminate GlobeNewswire

Apr. 27, 2026

OSE Immunotherapeutics se félicite de l'octroi de la désignation de médicament orphelin par la FDA du pegrizeprument (VEL-101) pour la prévention du rejet d’organe dans la transplantation cardiaque

Indeterminate GlobeNewswire

Apr. 27, 2026

Santhera erhält positive Stellungnahme des CHMP zur Ausweitung der Anwendung von AGAMREE® (Vamorolon) bei pädiatrischen DMD-Patienten ab zwei Jahren in der EU

Indeterminate GlobeNewswire

Apr. 27, 2026

Santhera Receives Positive CHMP Opinion to Expand AGAMREE® (vamorolone) Use in Pediatric DMD Patients Aged Two and Older in the EU

Indeterminate GlobeNewswire

Apr. 27, 2026

Dark Horse Consulting Group and Porton Advanced Announce Memorandum of Understanding Providing a Streamlined Path to Conducting IITs in China

Indeterminate GlobeNewswire